This topic contains a solution. Click here to go to the answer

Author Question: To implement a physical security program an organization must conduct a risk assessment to determine ... (Read 101 times)

geodog55

  • Hero Member
  • *****
  • Posts: 530
To implement a physical security program an organization must conduct a risk assessment to determine the amount of resources to devote to physical security and the allocation of those resources against the various threats.
 
  Indicate whether the statement is true or false.

Question 2

Incident response is part of the ________ class of security controls.
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

eliasc0401

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

T

Answer to Question 2

operational




geodog55

  • Member
  • Posts: 530
Reply 2 on: Jul 7, 2018
Thanks for the timely response, appreciate it


dawsa925

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

Most strokes are caused when blood clots move to a blood vessel in the brain and block blood flow to that area. Thrombolytic therapy can be used to dissolve the clot quickly. If given within 3 hours of the first stroke symptoms, this therapy can help limit stroke damage and disability.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library